Unul din obiectivele principale ale Life4me+ - să prevină apariția unor noi cazuri de infecție cu HIV, boli cu transmitere sexuală (TBS), hepatită C și tuberculoză

Aplicația permite stabilirea unei comunicări anonime între medici și persoane care au HIV. Îți permite să organizezi mai ușor programul de administrare a tratamentului și să setezi notificări personalizate și discrete

Toate știrile / Iunie 2018

Arhivă

✕

26 iunie 2018

7908

European Commission issued marketing authorization to Gilead for the drug Biktarvy

European Commission issued marketing authorization to Gilead for the drug Biktarvy

June 25, the pharmaceutical company Gilead Sciences Inc. announced that the European Commission has granted permission for the sale in Europe of the ART drug Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide). The drug, intended for the treatment of HIV-1 in ...

25 iunie 2018

6813

HIV-positive American wins $ 18 million in a lawsuit against the clinic

HIV-positive American wins $ 18 million in a lawsuit against the clinic

A forty-eight-year-old US resident Sean Stentiford was awarded $ 18 million compensation as a result of the trial in case of the clinic negligence, which failed to properly test him for HIV and to detect the virus in time.

21 iunie 2018

6547

Properties of protein viperin will help to create a universal drug for HIV and hepatitis С treatment

Properties of protein viperin will help to create a universal drug for HIV and hepatitis С treatment

A group of researchers in the United States has identified the mode of action of an interferon-inducible protein viperin, also known as RSAD2, that has antiviral effects on a wide range of different viruses such as influenza, hepatitis C, HIV, human cytomegalovirus and West ...

20 iunie 2018

5929

The current level of transmission of resistant strains of HIV in the US does not affect the outcome of treatment

The current level of transmission of resistant strains of HIV in the US does not affect the outcome of treatment

The current increase in the transmission of resistant HIV strains to US antiretrovirals will not affect the success of treatment for patients taking first-line drugs and will not affect the effectiveness of ART therapy in the near future, according to a large analysis published ...

19 iunie 2018

6325

The first kits for individual HIV testing were introduced in Switzerland

The first kits for individual HIV testing were introduced in Switzerland

On June 19, sales of the first officially approved tests for self-diagnosis for HIV started in Swiss pharmacies. This was reported yesterday at the Federal Public Health Administration. According to the SWI portal, all tests of the individual testing kits were approved by ...

18 iunie 2018

6021

The Hong Kong scientists discovered a universal antibody that neutralizes all HIV strains

The Hong Kong scientists discovered a universal antibody that neutralizes all HIV strains

A team of researchers from the University of Hong Kong reported on Friday that it was able to achieve "functional treatment" of HIV infection through the use of a special bispecific antibody. The main advantage of the latter, according to scientists, is its universality ...

18 iunie 2018

6191

Zimbabwe launches a large-scale pre-exposure HIV prevention program

Zimbabwe launches a large-scale pre-exposure HIV prevention program

The government of Zimbabwe last week launched a program for the distribution of pre-exposure HIV prevention (PrEP). This initiative, officials noted, is designed to reduce the risk of HIV transmission in at-risk groups.

15 iunie 2018

5846

Stigma can prevent women from receiving PrEP

Stigma can prevent women from receiving PrEP

Fear of being accused of having promiscuous sexual relations and discrimination because of HIV-positive status causes many women to refuse to take pre-exposure HIV prevention (PrEP), scientists from the George Washington University (USA) have established.

14 iunie 2018

6391

Double ART therapy of GSK demonstrated efficacy in the final stages of clinical trials

Double ART therapy of GSK demonstrated efficacy in the final stages of clinical trials

The British pharmaceutical company GlaxoSmithKline reported on Thursday that its experimental drug for HIV treatment, which is a fixed dosage of drugs dolutegravir and lamivudine (dual therapy), during the final stages of clinical trials achieved the set goals.

13 iunie 2018

6756

CytoDyn prepare the bid for a biological FDA license for a pilot drug from HIV

CytoDyn prepare the bid for a biological FDA license for a pilot drug from HIV

June 9, the pharmaceutical company CytoDyn Inc. announced the first positive results of the effectiveness of promising monoclonal antibody PRO140, intended for the treatment of HIV infection in combination with other antiretroviral drugs and allowing to prolong the effect ...

1 2